Date: July 1, 2012
InteRNA Technologies B.V. announces full consolidation of its subsidiary InteRNA Genomics B.V. as of July 1, 2012.
With this consolidation, the Company has secured the Intess™ software for miRNA analysis of next generation sequencing data sets. As a result, the website of InteRNA Genomics has been shut down, as are the services InterRNA Genomics provided to customers.
- InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatment
- November 27-28, 2012: EuroTIDES, Berlin, Germany
- November 8-11, 2012: Society for Melanoma Research Congress, Hollywood, USA
InteRNA will be very pleased to meet you during these events. For appointments or more information, please contact us at email@example.com
Currently we have no vacancies. If you wish to send an open application, please send your contact details with a resume to firstname.lastname@example.org.